Hosted on MSN1mon
Haemonetics targets 24% to 26% hospital revenue growth with momentum in hemostasis and vascular closureHospital revenue grew 24% on a reported basis, with standout performance in hemostasis management (26% U.S. revenue growth) and vascular closure through products like VASCADE MVP and MVP XL.
Hosted on MSN11mon
Research team develop porous sponge material for enhancing kidney hemostasis and repairMore information: Jae Yun Kim et al, Degradation-controlled tissue extracellular sponge for rapid hemostasis and wound repair after kidney injury, Biomaterials (2024). DOI: 10.1016/j.biomaterials.
IIT Kanpur's Materials Science and Engineering Department has developed a groundbreaking haemostatic sponge made from ...
The CN-3000 and CN-6000 Systems 1 offer an expansive test menu of routine and specialty hemostasis assays—including several INNOVANCE ® assays—all on a single instrument, allowing labs to run ...
We invite you to attend this virtual educational workshop. Our speakers will discuss state-of-the-art Hemostasis treatments, the role of the Hemostasis Laboratory, and how this can impact patient ...
All existing anticoagulants act on a pathway that is common to pathological thrombosis and physiological hemostasis. It is impossible to reduce thromboembolic events without affecting normal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results